dameng100 muucmf 1.9.5.20260309 /admin/extend/list.html Name cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 3.9 | $0-$5k | 0.52 |
Summary
A vulnerability has been found in dameng100 muucmf 1.9.5.20260309 and classified as problematic. This impacts an unknown function of the file /admin/extend/list.html. The manipulation of the argument Name leads to cross site scripting. This vulnerability is listed as CVE-2026-4848. The attack may be initiated remotely. In addition, an exploit is available. The vendor was contacted early about this disclosure but did not respond in any way.
Details
A vulnerability, which was classified as problematic, has been found in dameng100 muucmf 1.9.5.20260309. This issue affects an unknown part of the file /admin/extend/list.html. The manipulation of the argument name with an unknown input leads to a cross site scripting vulnerability. Using CWE to declare the problem leads to CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. Impacted is integrity.
The advisory is shared at thinhneee.github.io. The identification of this vulnerability is CVE-2026-4848. The exploitation is known to be easy. The attack may be initiated remotely. No form of authentication is needed for a successful exploitation. It demands that the victim is doing some kind of user interaction. Technical details as well as a public exploit are known. MITRE ATT&CK project uses the attack technique T1059.007 for this issue.
The exploit is available at thinhneee.github.io. It is declared as proof-of-concept. The vendor was contacted early about this disclosure but did not respond in any way. By approaching the search of inurl:admin/extend/list.html it is possible to find vulnerable targets with Google Hacking.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
Product
Vendor
Name
Version
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 4.3VulDB Meta Temp Score: 3.9
VulDB Base Score: 4.3
VulDB Temp Score: 3.9
VulDB Vector: 🔒
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Access: Public
Status: Proof-of-Concept
Download: 🔒
Google Hack: 🔒
EPSS Score: 🔒
EPSS Percentile: 🔒
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔒
Timeline
03/25/2026 Advisory disclosed03/25/2026 VulDB entry created
03/25/2026 VulDB entry last update
Sources
Advisory: thinhneee.github.ioStatus: Not defined
CVE: CVE-2026-4848 (🔒)
GCVE (CVE): GCVE-0-2026-4848
GCVE (VulDB): GCVE-100-353153
scip Labs: https://www.scip.ch/en/?labs.20161013
Entry
Created: 03/25/2026 15:56Changes: 03/25/2026 15:56 (56)
Complete: 🔍
Submitter: thinhnee
Cache ID: 216:690:103
Submit
Accepted
- Submit #776193: MuuCmf MuuCmf T6 cms 1.9.5.20260309 Improper Neutralization of Alternate XSS Syntax (by thinhnee)
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
No comments yet. Languages: en.
Please log in to comment.